Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Treatment Technologies & Insights (TTI) is a digital health company that specializes in patient-reported outcome (PRO) tracking and data analytics. The company's primary offering is ChemoWave, a mobile application designed for cancer patients to monitor symptoms, medication adherence, and lifestyle factors in real-time. TTI's platform aggregates this patient-generated data to provide actionable insights for clinicians, researchers, and pharmaceutical companies, aiming to improve treatment efficacy and patient well-being. Beyond oncology, the company is expanding its technology to support other chronic health conditions through personalized data tracking. By bridging the gap between daily patient experiences and clinical care, TTI seeks to optimize therapeutic outcomes through real-world evidence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Treatment Technologies & Insights.